Pfizer Establishes Potential US$50 M Drug Discovery Pact with University of California, San Diego
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 8 (Table of Contents)
Published: 19 Aug-2011
DOI: 10.3833/pdr.v2011.i8.1525 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Through its Centers for Therapeutic Innovation (CTI), Pfizer has entered into a drug discovery and development collaboration with the University of California, San Diego (UCSD) Health Sciences that is potentially worth as much as US$50 M over the next 5 years...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018